Powerful class of antioxidants may be potent Parkinson's treatment

A class of antioxidants called synthetic triterpenoids blocked development of Parkinson's in an animal model that develops the disease in a handful of days, said Dr. Bobby Thomas, neuroscientist at the Medical College of Georgia at Georgia Health Sciences University and corresponding author of the study in the journal Antioxidants & Redox Signaling. Thomas and his colleagues were able to block the death of dopamine-producing brain cells that occurs in Parkinson's by using the drugs to bolster Nrf2, a natural antioxidant and inflammation fighter.

Read more at: http://medicalxpress.com/news/2012-07-powerful-class-antioxidants-potent-parkinson.html#jCp
Enhanced by Zemanta

No comments: